Distinct transcriptional and functional properties of the R transactivator gene orf50 of the transforming herpesvirus saimiri strain C488

Virology

Volumn 268, Issue 1, 2000, Pages 167-177

  Thurau, Mathias ^a   Whitehouse, Adrian ^b   Wittmann, Sabine ^a   Meredith, David ^b   Fickenscher, Helmut ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN; TRANSACTIVATOR PROTEIN R; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATOR GENE; RNA SPLICING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; TRANSCRIPTION REGULATION;

ANIMALIA; DNA VIRUSES; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; SAIMIRI; SAIMIRIINE HERPESVIRUS 2;

EID: 0034053056     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0167     Document Type: Article

References (43)

1. Albrecht J. C., Nicholas J., Biller D., Cameron K. R., Biesinger B., Newman C., Wittmann S., Craxton M. A., Coleman H., Fleckenstein B., Honess R. W. Primary structure of the herpesvirus saimiri genome. J. Virol. 66:1992;5047-5058.
2. Biesinger B., Trimble J., Desrosiers R. C., Fleckenstein B. The divergence between two oncogenic herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology. 176:1990;505-514.
3. Biesinger B., Müller-Fleckenstein I., Simmer B., Lang G., Wittmann S., Platzer E., Desrosiers R. C., Fleckenstein B. Stable growth-transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. USA. 89:1992;3116-3119.
4. Biesinger B., Tsygankov A., Fickenscher H., Emmrich F., Fleckenstein B., Bolen J., Bröker B. The product of the herpesvirus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p56lck in transformed cells. J. Biol. Chem. 270:1995;4729-2734.
5. Cantello J. L., Anderson A. S., Morgan R. W. Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J. Virol. 68:1994;6280-6290.
6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
7. Cooper M., Goodwin D. J., Hall K. T., Stevenson A. J., Meredith D. M., Markham A. F., Whitehouse A. The gene product encoded by ORF57 of herpesvirus saimiri regulates the redistribution of the splicing factor SC-35. J. Gen. Virol. 80:1999;1311-1316.
8. Desrosiers R. C., Bakker A., Kamine J., Falk L., Hunt R., King N. A region of the herpesvirus saimiri genome required for oncogenicity. Science. 228:1985;184-187.
9. Desrosiers R. C., Burghoff R., Bakker A., Kamine J. Construction of replication-competent herpesvirus saimiri deletion mutants. J. Virol. 49:1984;343-348.
10. Desrosiers R. C., Silva D., Waldron L., Letvin N. Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization. J. Virol. 57:1986;701-705.
11. Duboise S. M., Guo J., Czajak S., Desrosiers R. C., Jung J. U. STP and Tip are essential for herpesvirus saimiri oncogenicity. J. Virol. 72:1998a;1308-1313.
12. Duboise S. M., Guo J., Czajak S., Lee H., Veazey R., Desrosiers R. C., Jung J. U. A role for herpesvirus saimiri orf14 in transformation and persistent infection. J. Virol. 72:1998b;6770-6776.
13. Fickenscher H., Fleckenstein B. Growth transformation of human T cells. Meth. Microbiol. 25:1998;573-603.
14. Fickenscher H., Biesinger B., Knappe A., Wittmann S., Fleckenstein B. Regulation of the herpesvirus saimiri oncogene stpC similar to that of T-cell activation genes, in growth-transformed human T lymphocytes. J. Virol. 70:1996;6012-6019.
15. Fickenscher H., Bökel C., Knappe A., Biesinger B., Meinl E., Fleischer B., Fleckenstein B., Bröker B. M. Functional phenotype of transformed human alpha/beta and gamma/delta T cells determined by different subgroup C strains of herpesvirus saimiri. J. Virol. 71:1997;2252-2263.
16. Hall K. T., Stevenson A. J., Goodwin D. J., Gibson P. C., Markham A. F., Whitehouse A. The activation domain of herpesvirus saimiri R protein interacts with the TATA-binding protein. J. Virol. 73:1999;9756-9763.
17. Jung J., Trimble J., King N., Biesinger B., Fleckenstein B., Desrosiers R. C. Identification of transforming genes of subgroup A and C strains of herpesvirus saimiri. Proc. Natl. Acad. Sci. USA. 88:1991;7051-7055.
18. Knappe A., Hiller C., Thurau M., Wittmann S., Hofmann H., Fleckenstein B., Fickenscher H. The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells. J. Virol. 71:1997;9124-9133.
19. Knappe A., Thurau M., Niphuis H., Hiller C., Wittmann S., Kuhn E. M., Rosenwirth B., Fleckenstein B., Heeney J., Fickenscher H. T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homology. J. Virol. 72:1998;3469-3471.
20. Koomey J., Mulder C., Burghoff R., Fleckenstein B., Desrosiers R. C. Deletion of DNA sequences in a nononcogenic variant of herpesvirus saimiri. J. Virol. 50:1984;662-665.
21. Kraft M. S., Henning G., Fickenscher H., Lengenfelder D., Tschopp J., Fleckenstein B., Meinl E. Herpesvirus saimiri transforms human T-cell clones to stable growth without inducing resistance to apoptosis. J. Virol. 72:1998;3138-3145.
22. Kretschmer C., Murphy C., Biesinger B., Beckers J., Fickenscher H., Kirchner T., Fleckenstein B., Rüther U. A herpes saimiri oncogene causes peripheral T-cell lymphoma in transgenic mice. Oncogene. 12:1996;1609-1616.
23. Lee H., Trimble J. J., Yoon D. W., Regier D., Desrosiers R. C., Jung J. U. Genetic variation of herpesvirus saimiri subgroup A transforming protein and its association with cellular src. J. Virol. 71:1997;3817-3825.
24. Lukac D. M., Kirshner J. R., Ganem D. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73:1999;9348-9361.
25. Lukac D. M., Renne R., Kirshner J. R., Ganem D. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology. 252:1998;304-312.
26. Medveczky P., Szomolanyi E., Desrosiers R. C., Mulder C. Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J. Virol. 52:1984;938-944.
27. Medveczky M. M., Szomolanyi E., Hesselton R., DeGrand D., Geck P., Medveczky P. G. Herpesvirus saimiri strains from three DNA subgroups have different oncogenic potentials in New Zealand white rabbits. J. Viol. 63:1989;3601-3611.
28. Murphy C., Kretschmer C., Biesinger B., Beckers J., Jung J., Desrosiers R. C., Müller-Hermelink H. K., Fleckenstein B., Rüther U. Epithelial tumors induced by a herpesvirus oncogene in transgenic mice. Oncogene. 9:1994;221-226.
29. Nicholas J., Coles L. S., Newman C., Honess R. W. Regulation of the herpesvirus saimiri (HVS) delayed-early 110-kilodalton promoter by HVS immediate-early gene products and a homolog of the Epstein-Barr virus R transactivator. J. Virol. 65:1991;2457-2466.
30. Nicholas J., Smith E. P., Coles L., Honess R. W. Gene expression in cells infected with gammaherpesvirus saimiri: Properties of transcripts from two immediate-early genes. Virology. 179:1990;189-200.
31. Prang N., Wolf H., Schwarzmann F. Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1. J. Virol. 69:1995;2644-2648.
32. Ragoczy T., Heston L., Miller G. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J. Virol. 72:1998;7978-7984.
33. Sawtell N. W., Poon D. K., Tansky C. S., Thomson R. L. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J. Virol. 72:1998;5343-5350.
34. Sun R., Lin S. F., Gradoville L., Yuan Y., Zhu F., Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA. 95:1998;10866-10971.
35. Sun R., Lin S. F., Staskus K., Gradoville L., Grogan E., Haase A., Miller G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73:1999;2232-2242.
36. Thompson R. L., Sawtell N. W. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J. Virol. 71:1997;5432-5440.
37. Whitehouse A., Carr I. M., Griffiths J. C., Meredith D. M. The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases. J. Virol. 71:1997a;2550-2554.
38. Whitehouse A., Stevenson A. J., Cooper M., Meredith D. M. Identification of a cis-acting element within the herpesvirus saimiri ORF 6 promoter that is responsive to the HVS.R transactivator. J. Gen. Virol. 78:1997b;1411-1415.
39. Whitehouse A., Cooper M., Hall K. T., Meredith D. M. The open reading frame (ORF) 50a gene product regulates ORF 57 gene expression in herpesvirus saimiri. J. Virol. 72:1998a;1967-1973.
40. Whitehouse A., Cooper M., Meredith D. M. The immediate-early gene product encoded by open reading frame 57 of herpesvirus saimiri modulates gene expression at a posttranscriptional level. J. Virol. 72:1998b;857-861.
41. Yao Z., Maraskovsky E., Spriggs M., Cohen J., Armitage R., Alderson M. Herpesvirus saimiri open reading frame 14, a protein encoded by a T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation. J. Immunol. 156:1996;3260-3266.
42. Zalani S., Holley-Guthrie E., Kenney S. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA. 93:1996;9194-9199.
43. Zhu F. X., Cusano T., Yuan Y. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73:1999;5556-5567.